Maze Therapeutics, Inc. · NASDAQ:MAZE

James N. Topper reported a 7.30% stake in Maze Therapeutics, Inc. (Schedule 13G)

Event Feb 3, 2025 · Filed Feb 10, 2025

James N. Topper reported a 7.30% stake in Maze Therapeutics, Inc., 3,193,900 shares, as a passive investor on Feb 3, 2025. Filed Feb 10, 2025 (Schedule 13G).

Stake: 7.30%
Shares: 3,193,900
Intent: Passive
What changed: Crossed above 5%
Filed together: 17 holders

The filing in full

Holder	Stake	Shares
Frazier Life Sciences Public Fund, L.P.	5.40%	2,376,329
FHMLSP, L.P.	5.40%	2,376,329
FHMLSP, L.L.C.	5.40%	2,376,329
Frazier Life Sciences Public Overage Fund, L.P.	1.60%	701,164
FHMLSP Overage, L.P.	1.60%	701,164
FHMLSP Overage, L.L.C.	1.60%	701,164
Frazier Life Sciences X, L.P.	0.10%	41,719
FHMLS X, L.P.	0.10%	41,719
FHMLS X, L.L.C.	0.10%	41,719
Frazier Life Sciences XI, L.P.	0.20%	74,688
FHMLS XI, L.P.	0.20%	74,688
FHMLS XI, L.L.C.	0.20%	74,688
James N. Topper	7.30%	3,193,900
Patrick J. Heron	7.30%	3,193,900
Albert Cha	7.00%	3,077,493
James Brush	7.00%	3,077,493
Daniel Estes	0.20%	74,688

Source

View original at SEC

Related